about
Factors associated with the development of expertise in heart failure self-careHigh-sensitivity ST2 for prediction of adverse outcomes in chronic heart failureACCF/AHA 2011 key data elements and definitions of a base cardiovascular vocabulary for electronic health records: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards.What is the best measure of daytime sleepiness in adults with heart failure?Modest increase in peak VO2 is related to better clinical outcomes in chronic heart failure patients: results from heart failure and a controlled trial to investigate outcomes of exercise training.Excessive daytime sleepiness is associated with poor medication adherence in adults with heart failureDouble jeopardy: the influence of excessive daytime sleepiness and impaired cognition on health-related quality of life in adults with heart failureMultiple biomarkers for risk prediction in chronic heart failure.Predictors of objectively measured medication nonadherence in adults with heart failureAn overview of solid organ transplantation.Determinants of excessive daytime sleepiness and fatigue in adults with heart failureStage B heart failure: management of asymptomatic left ventricular systolic dysfunction.An uncommon presentation of an uncommon disease: leprosy in a heart transplant recipient.In the clinic. Heart failure.Validation of prognostic models among patients with advanced heart failure.A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home.Caveat emptor: the need for evidence, regulation, and certification of home telehealth systems for the management of chronic conditions.Stressful sleeping.Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators.Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression.The effects of race on peak oxygen consumption and survival in patients with systolic dysfunction.ACCF/AHA 2011 Key Data Elements and Definitions of a Base Cardiovascular Vocabulary for Electronic Health RecordsElectronic and telemedicine techniques to manage heart failureClinical exacerbations as a surrogate end point in heart failure researchA time to be born and a time to dieRegular nurse follow up calls may improve time to hospitalisation, but not other outcomes, for people with heart failure. CommentaryConstrictive pericarditis presenting as a late complication of epicardial ventricular tachycardia ablationPharmacokinetic monitoring of mycophenolic acid in heart transplant patients: correlation the side-effects and rejections with pharmacokinetic parametersAntibody-mediated rejection in heart transplant patients: long-term follow up of patients with high levels of donor-directed anti-DQ antibodies
P50
Q23910321-120C0BCB-A304-4390-867F-2ADBCE7A4019Q24610732-73F9CDF9-E05C-4CFE-9E24-72C3B77BF7ABQ33925055-38B2945D-1DDA-4F30-9305-EF3ABD490DC7Q34034057-307F04AE-03B4-4BE5-9281-F3B4CD489AAAQ34660754-7E63F3FD-BD9B-4FCE-97B0-69FC981CE630Q34777699-E8C1E1A3-FBF8-438B-B71A-6B16F7BDEADCQ36050632-8F2BFB7E-7F5B-4D4A-BC70-21407B19203CQ36070049-5A93D675-1007-4A92-AEB9-C86C28352B43Q36117811-C54D58D7-1642-4342-8034-F58C0B9D3C00Q36303248-D3309E85-38B5-43C9-8841-07E917EC57F3Q36407746-1CE9D858-C15F-444F-AEC3-AE2145B9ACCFQ36511753-EAA37E6A-0ADE-48D9-A68D-E5661859993FQ36526159-E9B292CC-263F-47B8-AA06-9F8DD8F8A582Q37761808-B2942A3D-D8C4-4F11-B716-B0722EAFE6C0Q43945907-D8A477ED-AA54-4BF4-8233-5D75D77303A9Q45082988-2B164C8F-0DBE-41A7-B952-4F02CBF8215CQ45098472-A220C6A8-03EE-4BE0-86DD-F3A1DD05F9BFQ48384551-E74D0B70-A603-4F88-BD32-34B56C0BEAB6Q53174819-7C4B12A2-BD98-4814-88E7-F6604997B467Q53281094-508F3F38-4710-47FF-AB32-0B7674B5FF90Q54513921-FA4D92BB-C360-49D9-AF5D-72B643767FE9Q57630482-E4251947-0060-4A50-8E70-6E35853019D2Q80349188-0C0CDFDB-B8D4-48F3-B924-AC78F72BD490Q80517604-F97845BD-3112-4055-8437-942898B8A7D3Q80656686-39501AAB-4429-49DB-9342-7E745F30CFA8Q82095093-D49098EF-09B8-4D13-881C-6C2B4AA7F6CCQ83721396-CB976300-6D8E-4D05-B41A-E8BD688DCA75Q83786041-4E0A02D3-49C4-4BCD-B49A-87F026C02998Q84512222-022EE10F-24D1-4617-B95A-DE195A819D9C
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Lee R Goldberg
@ast
Lee R Goldberg
@en
Lee R Goldberg
@es
Lee R Goldberg
@nl
Lee R Goldberg
@sl
type
label
Lee R Goldberg
@ast
Lee R Goldberg
@en
Lee R Goldberg
@es
Lee R Goldberg
@nl
Lee R Goldberg
@sl
prefLabel
Lee R Goldberg
@ast
Lee R Goldberg
@en
Lee R Goldberg
@es
Lee R Goldberg
@nl
Lee R Goldberg
@sl
P106
P31
P496
0000-0002-7906-9638